Navigation Links
SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland
Date:9/28/2008

ST. LOUIS, Sept. 29 /PRNewswire-FirstCall/ -- SAFC Pharma(TM), a focus area within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL), today announced that a new reactor at its Arklow (Ireland) manufacturing site has begun operation, expanding the facility's capacity for large-scale active pharmaceutical ingredient (API) manufacturing by approximately 15%. The new reactor is the latest in a series of investments designed to enhance production capacity and expand capabilities at the Arklow site, which is the company's global center for the production of commercial and late-stage APIs and advanced intermediates.

The $4-million project involved the installation and start-up of a 6,000 liter Hastalloy(R) reactor for large-scale API manufacturing, increasing the total capacity at the site to 96,000 liters, with a reactor range from 250 to 8,000 liters. This latest investment adds capacity for both large- and small-scale manufacturing and improves upon the site's award-winning environmental performance. The Arklow site is a recognized leader in setting environmental standards and received the PharmaChem Ireland's Responsible Care 2006 Award in the "Environment" category for development of an imaginative approach to reduce and recycle its solvent waste from API processing.

Commenting on the latest expansion in SAFC's global manufacturing, SAFC Pharma Vice President Europe, Dr. Michael Harris commented, "Our continued investment in capabilities and capacity is a direct reflection of SAFC's long-term commitment to meeting customer requirements for API manufacturing. Our continuing investments in facilities and personnel support the growth of SAFC Pharma and underline our position as an industry leader whose focus includes th
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
2. Novagali Pharma Completes a EUR15 Million Fund Raising
3. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
4. Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
7. New USP 797 Regulations May Create New Hazards for Compounding Pharmacy Directors
8. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
9. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
10. AIT Laboratories Expands Pharma Services
11. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Dec. 2 Reportlinker.com announce...n its catalogue: ,, Drug Discovery Technologie...nities ,, http://www.reportlinker.com/p016424...-Market-Trends--Opportunities.html ,, Drug dis...of every pharmaceutical company,s business strateg...
(Date:12/2/2009)...ec. 2 The world,s first concept de...gy, a breakthrough alternative to replace a petroc...f synthetic rubber with renewable biomass, made th...ire will be on display at a lounge in the common d...ort throughout December 21, while the other tire w...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biote...NASDAQ: ONCY ) announced today that in connection ...nderwriters have exercised in full their over-allo...nits. Each unit is comprised of one common share a... sold at a price of US$3.00 per unit. Each whole c...
(Date:12/2/2009)... The Netherlands, December 2 Pepsc... company focusing on protein mimicking,technology ...nounced that it,has appointed Wim E.M. Mol, Ph.D. ... will be responsible for all of Pepscans corporate...c direction of the company. He brings to,Pepscan m...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
... to increase per capita income, retain more colleg...dvancement options, the state announced Thursday a...plete baccalaureate degree programs. , ,The announ... Bay , is part of the state,s strategy to play cat...elor,s degrees. Seven programs have been selected ...
...nsin biotech companies had their chance to be hear...the University of Wisconsin-Madison campus, planne... governor arrived with two of the state,s top stem...e, and this is the right time, for stem cell resea...m Brazil to be a part of the university here. Over...
...ve to comply with federal requirements, Fiserv, I...urity provider, as a partner in providing multifac...redit union clients. , ,The move comes as financia... 2006, to comply with Federal Financial Institutio...d strengthen their customer authentication procedu...
Other Biology Technology:State commits $500,000 to boost bachelor's degrees 2Discovery makes Wisconsin go 'round at BIO Chicago 2Discovery makes Wisconsin go 'round at BIO Chicago 3
(Date:12/2/2009)...smokeless tobacco product called moist snuff plac...esota to urge the tobacco industry to change manuf...rcinogens. Their study is published online in ACS,.... It reports that this category of tobacco product...ic and cancer-causing substances. Called polycycli...
(Date:12/2/2009)...DWOOD SHORES, Calif. and PALM HARBOR, Fla., Dec. 2...nce Corporation ("CIC") (OTC Bulletin Board: CICI)...ions for business process automation in the financ...tric signature verification and Docubase Systems I...ic Document Management (EDM) software provider ann...
(Date:12/2/2009)...r 2, 2009 Commonly prescribed beta 2 adrenergic a...nt women as well as pre-term labor may increase th...ric pathology, cognitive problems and poor school ...study published in the December 2009 issue of the ... Beta 2 adrenergic agonist drugs as a class are wi...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2INHS Brings Health Information Technology Conference to Spokane 52550 1INHS Brings Health Information Technology Conference to Spokane 52550 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 1Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 3Risky driving puts P platers at high danger of crash 52541 1Risky driving puts P platers at high danger of crash 52541 2
... requires activation of a molecule on the surface ...hway the virus uses in its insidious attack on the...rs will report at the XVI International AIDS Confe... role for B cells in the development and spread of...r future studies and drug development efforts that...
... packaged in a tiny sphere penetrates deeply into ... protein and drastically reducing the size of tumo...nderson Cancer Center report in the Aug. 15 editio...experiment, featured on the cover of the journal, ...terfering RNA (siRNA) to attack cancer, says senio...
...is week reveal that at least some primates can use...l for guiding their foraging behavior when searchi... informs our understanding of how cognitive skills...ed by Karline Janmaat, Richard Byrne, and Klaus Zu...June 20th issue of Current Biology. , The questio...
Other Biology News:HIV infection requires an accomplice: B cells with special protein direct HIV to T cells 2Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial 2Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial 3Primates take weather into account when searching for fruits 2
Thermal Printer Paper from Promega
Dr. P Set - Human Fetal Normal Tissue: Umbilical Cord from BioChain
Self Closing Forceps from Applied Biosystems
...ubes to 1 outflow Single-cell and patch delivery ...l millisecond) solution change Very small dead vo..., Solid construction 360, 250 and 100 micron del...cromanipulator Available in 4, 8, and 16 channels...
Biology Products: